Total Payments
$851.59
2022 Payments
$24.46
Companies
7
Transactions
32
Medicare Patients
402
Medicare Billing
$110,574
Payment Breakdown by Category
Food & Beverage$851.59 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $851.59 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $378.76 | 15 | $0 (2022) |
| Gilead Sciences, Inc. | $229.74 | 2 | $0 (2019) |
| GlaxoSmithKline, LLC. | $96.88 | 6 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $67.80 | 4 | $0 (2017) |
| PFIZER INC. | $44.52 | 3 | $0 (2017) |
| Hikma Pharmaceuticals USA | $18.60 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.29 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $24.46 | 1 | AstraZeneca Pharmaceuticals LP ($24.46) |
| 2021 | $139.74 | 7 | AstraZeneca Pharmaceuticals LP ($139.74) |
| 2019 | $241.62 | 9 | Gilead Sciences, Inc. ($110.36) |
| 2018 | $44.99 | 3 | GlaxoSmithKline, LLC. ($44.99) |
| 2017 | $400.78 | 12 | AstraZeneca Pharmaceuticals LP ($151.35) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/19/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Respiratory | ||||||
| 11/15/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Respiratory | ||||||
| 11/01/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Respiratory | ||||||
| 10/04/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Respiratory | ||||||
| 09/13/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Respiratory | ||||||
| 08/09/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/21/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/24/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Respiratory | ||||||
| 09/11/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: Respiratory | ||||||
| 08/08/2019 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $110.36 | General |
| Category: HBV | ||||||
| 07/18/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Respiratory | ||||||
| 05/06/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2019 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/17/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Respiratory | ||||||
| 02/26/2019 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: VACCINES | ||||||
| 01/23/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Respiratory | ||||||
| 09/14/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: VACCINES | ||||||
| 08/01/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: RESPIRATORY | ||||||
| 01/09/2018 | GlaxoSmithKline, LLC. | ADVAIR (Drug), ANORO, BREO | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2017 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 11/02/2017 | Gilead Sciences Inc | Epclusa (Drug) | Food and Beverage | In-kind items and services | $119.38 | General |
| Category: HCV | ||||||
| 10/04/2017 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 09/21/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $117.75 | General |
| Category: Respiratory | ||||||
| 09/20/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 169 | 607 | $67,435 | $47,140 |
| 2021 | 6 | 142 | 489 | $51,680 | $32,029 |
| 2020 | 2 | 91 | 425 | $49,940 | $31,405 |
Total Patients
402
Total Services
1,521
Medicare Billing
$110,574
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 398 | $40,000 | $28,879 | 72.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 122 | $17,260 | $11,401 | 66.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 27 | 27 | $5,375 | $3,923 | 73.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 29 | 60 | $4,800 | $2,938 | 61.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 260 | $26,000 | $16,676 | 64.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 74 | $10,360 | $7,413 | 71.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 19 | 61 | $6,100 | $3,261 | 53.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 44 | $3,540 | $2,024 | 57.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 15 | 28 | $3,920 | $2,003 | 51.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 12 | 22 | $1,760 | $652.05 | 37.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 186 | $26,040 | $16,759 | 64.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 47 | 239 | $23,900 | $14,646 | 61.3% |
About Dr. Phac Vo, MD
Dr. Phac Vo, MD is a General Practice healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205913654.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Phac Vo, MD has received a total of $851.59 in payments from pharmaceutical and medical device companies, with $24.46 received in 2022. These payments were reported across 32 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($851.59).
As a Medicare-enrolled provider, Vo has provided services to 402 Medicare beneficiaries, totaling 1,521 services with total Medicare billing of $110,574. Data is available for 3 years (2020–2022), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Location Long Beach, CA
- Active Since 11/01/2006
- Last Updated 07/08/2007
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1205913654
Products in Payments
- SYMBICORT (Drug) $180.96
- BREZTRI (Drug) $130.40
- Epclusa (Drug) $119.38
- Vemlidy (Drug) $110.36
- LYRICA (Drug) $44.52
- JANUVIA (Drug) $38.69
- SHINGRIX (Biological) $36.33
- FARXIGA (Drug) $33.80
- BEVESPI AEROSPHERE (Drug) $33.60
- BREO (Drug) $29.73
- ASMANEX (Drug) $29.11
- Mitigare (Drug) $18.60
- ANORO (Drug) $17.82
- STIOLTO RESPIMAT (Drug) $15.29
- ADVAIR (Drug) $13.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Long Beach
Dr. Robert Campbell, D.d.s, D.D.S
General Practice — Payments: $610,386
General Practice $610,386
Dr. Michael Jensen, D.d.s, D.D.S
General Practice — Payments: $17,472
General Practice $17,472
Dr. Marc Lapinel, Dds, DDS
General Practice — Payments: $8,283
General Practice $8,283
Jeffrey Cohen, D.d.s, D.D.S
General Practice — Payments: $6,571
General Practice $6,571
Dr. Atef Boutros, Dds, DDS
General Practice — Payments: $6,405
General Practice $6,405
Dr. Henrico Mungcal, M.d, M.D
General Practice — Payments: $4,644
General Practice $4,644